Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial
Top Cited Papers
- 1 February 2004
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 363 (9409) , 600-607
- https://doi.org/10.1016/s0140-6736(04)15591-8
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Chlamydiaspecies as a cause of community-acquired pneumonia in CanadaEuropean Respiratory Journal, 2003
- Infectious Disease Outbreaks in Nursing Homes: An Unappreciated Hazard for Frail Elderly PersonsClinical Infectious Diseases, 2003
- The Future Diagnostic Role of Procalcitonin Levels: The Need for Improved SensitivityClinical Infectious Diseases, 2003
- Azithromycin for acute bronchitis: a randomised, double-blind, controlled trialThe Lancet, 2002
- Bacterial Infection in Chronic Obstructive Pulmonary Disease in 2000: a State-of-the-Art ReviewClinical Microbiology Reviews, 2001
- Calcitonin precursors are reliable markers of sepsis in a medical intensive care unitCritical Care Medicine, 2000
- Editorial Response: Managing Antibiotic Use‐Impact of Infection ControlClinical Infectious Diseases, 1999
- Procalcitonin — A new indicator of the systemic response to severe infectionsInfection, 1997
- Antibiotic treatment of community-acquired pneumonia in clinical practice: a European perspectiveJournal of Antimicrobial Chemotherapy, 1995
- High serum procalcitonin concentrations in patients with sepsis and infectionPublished by Elsevier ,1993